Bioretec Oy

Equities

BRETEC

FI4000480454

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Helsinki Other stock markets 11:15:37 2024-05-21 am EDT			5-day change	1st Jan Change
2.69 ^EUR	+0.37%		0.00%	+12.08%

May. 21	Medical Device Company Bioretec Names New CEO	MT
Apr. 05	Bioretec Oy Announces Pekka Simula Not Available for Re-Election to Board of Directors	CI

Bioretec Oy Announces Appointment of Päivi Malinen as Member of the Board of Directors

April 13, 2022 at 08:00 am EDT

Bioretec Oy announced at the AGM held on April 13, 2022 that the company approved Päivi Malinen is elected as a new member of the Board of Directors for a term starting at the end of the Annual General Meeting and expiring at the closing of the 2023 Annual General Meeting.

Latest news about Bioretec Oy

Medical Device Company Bioretec Names New CEO	May. 21	MT
Bioretec Oy Announces Pekka Simula Not Available for Re-Election to Board of Directors	Apr. 05	CI
Finland's Bioretec Gets US Patent Allowance for Magnesium Alloy Composition	Mar. 22	MT
Bioretec Ltd. Receives a Patent by the U.S. Patent Office for its RemeOs Magnesium Alloy Composition	Mar. 21	CI
Bioretec Secures US FDA Breakthrough Device Designation for Spinal Interbody Cage Implant	Mar. 14	MT
Bioretec Has Been Granted FDA Breakthrough Device Designation Status for its RemeOs Spinal Interbody Cage	Mar. 14	CI
Bioretec Expects EU Regulatory Approval for Trauma Screw in Q2	Mar. 11	MT
Bioretec's European Market Authorization for RemeOs Trauma Screw Proceeded to Expert Panel Evaluation	Mar. 08	CI
Bioretec to Initiate Search for New CEO	Nov. 16	MT
Bioretec Ltd Announces CEO Changes	Nov. 16	CI
Bioretec Estimates the Approval of the European Market Authorization for the Biodegradable RemeOs? Trauma Screw Will Move to the First Quarter of 2024	23-10-18	CI
Bioretec Secures Distribution Agreement for Trauma Screws in US Market	23-09-12	MT
Bioretec Signs Distribution Deal for Launch of Orthopedic Product in US	23-09-12	MT
Bioretec Ltd. Enters into the U.S. Distribution Agreement with Spartan Medical Inc. for the RemeOs Screws	23-09-12	CI
Bioretec Wins R&D Grant from Business Finland for Developing Advanced Biodegradable Implants	23-09-06	MT
Bioretec Ltd Unveils Its Revitalized Scientific Advisory Board	23-08-16	CI
Bioretec Oy Appoints Esa Hallinen as Director of Operations and Member of the Management Team	23-07-14	CI
Bioretec Ltd Acquires New CNC Machining Center to Increase Production Capacity of RemeOs Products at its Factory in Tampere, Finland	23-06-13	CI
Bioretec Oy Approves Management Appointments	23-05-26	CI
Bioretec Ltd Appoints Dr. Jeremy Dublon as Regulatory Advisor	23-05-16	CI
Bioretec Ltd, Receives U.S. Market Authorization for Its RemeOs Trauma Screw from the U.S. Food and Drug Administration	23-04-24	CI
Bioretec Wins US FDA Nod for Bioresorbable Orthopedic Implant	23-03-30	MT
Bioretec Ltd Receives Market Authorization of the U.S. Food and Drug Administration for Its Pioneering Remeos Traversed with the Clinical Trial	23-03-30	CI
Bioretec Submits Additional Data Requested By US FDA For Trauma Screw	23-01-03	MT
Bioretec Ltd Submits Additional Information Requested by the FDA for US Registration of RemeOs Trauma Screws	23-01-03	CI

Chart Bioretec Oy

Duration

Period

More charts

Company Profile

Bioretec Oy is a Finland-based medical device manufacturer company focusing on the development of strong, safe and reliable bioresorbable implants for pediatric and adult orthopedics. The Company operates as a developer, manufacturer and commercializer of innovative bioresorbable orthopedic implants and implant materials used for the treatment of bone and soft tissue injuries. Bioretec Oyâs existing Activa product portfolio consists of bioabsorbable biopolymer products that are alreadyavailable in the market for applications in pediatrics, trauma surgery as well as sports surgery. Bioretec Oy has one Germany-based subsidiary, BRI.Tech GmbH. The Companyâs products are used all over the world.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-14 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Bioretec Oy

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2.69 EUR

Average target price

3.85 EUR

Spread / Average Target

+43.12%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical Equipment

	1st Jan change	Capi.
BIORETEC OY	+12.08%	59.2M
SHOCKWAVE MEDICAL, INC.	+72.98%	12.38B
PENUMBRA, INC.	-20.40%	7.81B
MASIMO CORPORATION	+6.24%	6.72B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+12.78%	5.39B
APT MEDICAL INC.	+38.73%	5.03B
GETINGE AB	-16.79%	4.72B
ASAHI INTECC CO., LTD.	-23.81%	4.06B
INARI MEDICAL, INC.	-29.57%	2.68B
NOVOCURE LIMITED	+52.38%	2.59B

Medical Equipment